TRV-2026-1695Certified recordPeer-reviewed

Artificial Intelligence as a Catalyst for Cell-Based Therapies in Retinal Disease

Retinal degenerative diseases, including age-related macular degeneration (AMD), retinitis pigmentosa (RP), and Stargardt disease, represent leading causes of irreversible vision loss worldwide, collectively affecting hundreds of millions of people. Cell-based therapies, particularly those leveraging induced pluripotent stem cells (iPSCs), retinal pigment epithelium (RPE) transplantation, and CRISPR-Cas9 gene editing, have emerged as promising treatment modalities that may preserve, replace, or partially restore…

Health · The Trace — both readings · certified 2026-10-17 · v1 · article view · machine-readable

Current reading — gain

AI tools could make retinal cell therapies more efficient, reproducible and personalized by supporting patient selection, stem cell quality control, gene-editing checks, manufacturing and post-transplant imaging follow-up.

Current reading — problem

AI's necessity for retinal cell therapy is unproven, and data scarcity, interpretability, regulatory compliance and clinical validation remain unresolved.

What this doesn’t fix

The proposed AI pipeline is a forward-looking framework that has not been clinically validated, and the authors say AI's necessity for these therapies has not been demonstrated.

Evidence

  • Peer-reviewedCells2026-10-16
Reader signal

How should this claim be treated?

Cite this record

Truvace Impact Record TRV-2026-1695, v1: “Artificial Intelligence as a Catalyst for Cell-Based Therapies in Retinal Disease.” Truvace, 2026-10-17. /record/TRV-2026-1695 (accessed at citation time). sha256 d8225a660ea2748e…

Calibration history

Every change to this record since certification, in the open. None yet — the reading has held since it entered the record.

  1. Certifiedv1d8225a660ea2…

    Certified into the record

Verify this record
How to verify without trusting this page

Fetch the canonical text of any version from /api/record/TRV-2026-1695 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.